Format

Send to

Choose Destination
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2387. doi: 10.1016/j.cgh.2019.05.016.

Fibrosis Changes in the Placebo Arm of NASH Clinical Trials.

Author information

1
Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri.
2
Department of Internal Medicine, University of Nevada, Las Vegas, Nevada.
3
Division of Digestive and Liver Diseases, Cedars Sinai Medical Center, Los Angeles, California.
4
Evidence-based Practice Center, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
5
Fatty Liver Program, Division of Digestive and Liver Diseases, Comprehensive Transplant Program, Cedars Sinai Medical Center, Los Angeles, California.
PMID:
31543242
DOI:
10.1016/j.cgh.2019.05.016

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center